Context Therapeutics gets $100M financing deal and a key FDA approval

Context Therapeutics is advancing its experimental therapy being developed to treat solid tumors in gynecologic and testicular cancers.

Source: bizjournals.com Health Care:Biotechnology headlines - May 2, 2024 Category: Biotechnology Authors: John George Source Type: news